Circulating fibrinogen is a prognostic and predictive biomarker in malignant pleural mesothelioma

被引：0
|
作者：
B Ghanim
M A Hoda
T Klikovits
M-P Winter
A Alimohammadi
M Grusch
B Dome
M Arns
P Schenk
M Jakopovic
M Samarzija
L Brcic
M Filipits
V Laszlo
W Klepetko
W Berger
B Hegedus
机构：
[1] Medical University of Vienna,Division of Thoracic Surgery, Department of Surgery
[2] Institute of Cancer Research,Department of Internal Medicine I
[3] Medical University of Vienna,Department of Thoracic Surgery
[4] National Koranyi Institute of Pulmonology,Department of Pulmonology
[5] National Institute of Oncology,Department for Respiratory Diseases Jordanovac
[6] LKH Hochegg,Department of Biological Physics
[7] University of Zagreb,undefined
[8] School of Medicine,undefined
[9] University Hospital Center,undefined
[10] University of Zagreb,undefined
[11] School of Medicine,undefined
[12] Institute of Pathology,undefined
[13] Eötvös University,undefined
[14] MTA-SE Molecular Oncology Research Group,undefined
[15] Hungarian Academy of Sciences,undefined
来源：
British Journal of Cancer | 2014年 / 110卷
关键词：
malignant pleural mesothelioma; fibrinogen; prognosis; predictive biomarker; multimodality therapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：984 / 990
页数：6
相关论文
共 50 条
  • [31] A proteomics-based approach identifies secreted protein acidic and rich in cysteine as a prognostic biomarker in malignant pleural mesothelioma
    Steven C Kao
    Michaela B Kirschner
    Wendy A Cooper
    Thang Tran
    Sjaak Burgers
    Casey Wright
    Tiny Korse
    Daan van den Broek
    James Edelman
    Michael Vallely
    Brian McCaughan
    Nick Pavlakis
    Stephen Clarke
    Mark P Molloy
    Nico van Zandwijk
    Glen Reid
    British Journal of Cancer, 2016, 114 : 524 - 531
  • [32] Inflammatory Biomarkers as Prognostic Factors for Malignant Pleural Mesothelioma
    Yerigeri, K.
    Morrow, B.
    Steinberg, S. M.
    Sengupta, M.
    Hassan, R.
    Puthiamadathil, J.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S388 - S388
  • [33] Prognostic role of osteopontin expression in malignant pleural mesothelioma
    Cappia, Susanna
    Righi, Luisella
    Mirabelli, Dario
    Ceppi, Paolo
    Bacillo, Elisa
    Ardissone, Francesco
    Molinaro, Luca
    Scagliotti, Giorgio V.
    Papotti, Mauro
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2008, 130 (01) : 58 - 64
  • [34] Clinical and biologic prognostic factors in malignant pleural mesothelioma
    Ambrogi, Vincenzo
    Mineo, Tommaso Claudio
    THORACIC CANCER, 2012, 3 (04) : 289 - 302
  • [35] A proteomics-based approach identifies secreted protein acidic and rich in cysteine as a prognostic biomarker in malignant pleural mesothelioma
    Kao, Steven C.
    Kirschner, Michaela B.
    Cooper, Wendy A.
    Tran, Thang
    Burgers, Sjaak
    Wright, Casey
    Korse, Tiny
    van den Broek, Daan
    Edelman, James
    Vallely, Michael
    McCaughan, Brian
    Pavlakis, Nick
    Clarke, Stephen
    Molloy, Mark P.
    van Zandwijk, Nico
    Reid, Glen
    BRITISH JOURNAL OF CANCER, 2016, 114 (05) : 524 - 531
  • [36] Development and Validation of a Prognostic Signature for Malignant Pleural Mesothelioma
    Zhou, Jian-Guo
    Zhong, Hua
    Zhang, Juan
    Jin, Su-Han
    Roudi, Raheleh
    Ma, Hu
    FRONTIERS IN ONCOLOGY, 2019, 9
  • [37] Prognostic factors and the prognostic role of inflammation indices in malignant pleural mesothelioma
    Ebinc, Senar
    Oruc, Zeynep
    Kalkan, Ziya
    Karhan, Ogur
    Urakci, Zuhat
    Kucukoner, Mehmet
    Kaplan, Muhammet Ali
    Abdurrahman, Isikdogan
    TURK GOGUS KALP DAMAR CERRAHISI DERGISI-TURKISH JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2023, 31 (01): : 105 - 115
  • [38] Circulating Tumor Cells (CTCs) in Malignant Pleural Mesothelioma (MPM)
    Kazue Yoneda
    Fumihiro Tanaka
    Nobuyuki Kondo
    Masaki Hashimoto
    Teruhisa Takuwa
    Seiji Matsumoto
    Yoshitomo Okumura
    Noriaki Tsubota
    Ayuko Sato
    Tohru Tsujimura
    Kozo Kuribayashi
    Kazuya Fukuoka
    Chiharu Tabata
    Takashi Nakano
    Seiki Hasegawa
    Annals of Surgical Oncology, 2014, 21 : 472 - 480
  • [39] Pleural thickness after neoadjuvant chemotherapy is a prognostic factor in malignant pleural mesothelioma
    Hashimoto, Masaki
    Takeuchi, Jiro
    Takuwa, Teruhisa
    Kuroda, Ayumi
    Nakamura, Akifumi
    Nakamichi, Toru
    Matsumoto, Seiji
    Kondo, Nobuyuki
    Nakano, Takashi
    Morimoto, Takeshi
    Hasegawa, Seiki
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2019, 157 (01) : 404 - 413
  • [40] CD74: a new prognostic factor for patients with malignant pleural mesothelioma
    C Otterstrom
    A Soltermann
    I Opitz
    E Felley-Bosco
    W Weder
    R A Stahel
    F Triponez
    J H Robert
    V Serre-Beinier
    British Journal of Cancer, 2014, 110 : 2040 - 2046
12345